Comment on: Developments in outpatient parenteral antimicrobial therapy (OPAT) for Gram-positive infections in Europe, and the potential impact of daptomycin

J Antimicrob Chemother. 2009 Dec;64(6):1347. doi: 10.1093/jac/dkp379. Epub 2009 Oct 19.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Anti-Bacterial Agents / therapeutic use*
  • Bacterial Infections / drug therapy*
  • Daptomycin / therapeutic use*
  • Europe
  • Humans
  • Outpatients

Substances

  • Anti-Bacterial Agents
  • Daptomycin